Clayton, Dubilier & Rice Names FitzGerald As Operating Advisor

Jan 9 2017 | 5:22pm ET

Private equity manager Clayton, Dubilier & Rice (CD&R) has appointed Liam FitzGerald, former CEO of UDG Healthcare Plc, as an operating advisor.

FitzGerald will work out of CD&R’s London office, the company said in a statement. 

As CEO of UDG Healthcare from 2000 until 2016, he expanded the business from a mainly Irish-based distribution services business into a multi-faceted and multi-national healthcare services group operating in 20 countries. During that period, the company’s market capitalization increased by more than 500 percent and earnings grew at a compound annual rate of more than 20 percent. Moreover, FitzGerald is credited with leading and seamlessly integrating more than 30 acquisitions into the parent company. 

“Liam is a recognized leader who has a demonstrated record of driving sustained enterprise growth, market share gains and value creation on a global scale,” said CD&R partner David Novak, in the statement. “He brings valuable healthcare industry expertise, deep market insights and a broad network, particularly in Europe where we are enthusiastic about the investment opportunities presented by strong secular trends in the healthcare space.”

Prior to serving as CEO of UDG Healthcare, Mr. FitzGerald was the company’s director of healthcare supply chain from 1996 until 2000, and was business development manager for the company’s drug distribution unit from 1993 until 1996. 

Founded in 1978, New York-based CD&R is a private investment firm that has managed the investment of $22 billion in 72 businesses since inception.


In Depth

Exotic Assets: Investing In Rare Violins

Jan 17 2017 | 4:43pm ET

By definition, alternative investments include exotic assets far beyond your typical...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

DarcMatter: The Top Trends in Alternative Investments for 2017

Jan 13 2017 | 8:22pm ET

The $7 trillion alternative investments industry is poised for continued growth...

 

From the current issue of

The healthcare sector went on a tear beginning in 2011, thanks in large part to the passage of the Affordable Care Act and its impending implementat